Home
|
Contact Us
|
Site Map
|
Search
About Us
About Us Home
Management Team
Board of Directors
Development Team
Locations
Contact Us
History
Pipeline
Drug Pipeline Home
Our Goal
Therapeutic Areas
Drug Development Team
Clinical Trials
Publications
Discovery
Discovery Home
Discovery Process
Technology
Genome5000
Medicinal Chemistry
Biotherapeutics
Patents
Academic Access
Technology Licensing
Alliances
Alliances Home
Current Alliances
Technology Licensing
Careers
Careers Home
Opportunities
Our Culture
Benefits
Community Involvement
The Woodlands
Princeton
Awards and Recognition
News
News Home
Media Inquiries
Investors
Investors Home
Media
Events
Stock Quote
SEC Filings
Annual Reports
Corporate Governance
Request Information
News Home
Media Inquiries
Subscribe
Home
> News
Press Releases
Filter
Display #
5
10
15
20
25
30
50
100
All
04/16/2008
Lexicon's Drug Candidate for Rheumatoid Arthritis, LX2931, Shows Positive Results in Phase 1 Clinical Trial
04/15/2008
Lexicon Presents Clinical Data for LX6171, a Drug Candidate for Cognitive Disorders
03/19/2008
Lexicon Pharmaceuticals to Present at the Future Leaders in the Biotech Industry Conference
03/14/2008
Lexicon Pharmaceuticals 2007 Annual Report to Stockholders Available Online
03/06/2008
Lexicon Pharmaceuticals Reports 2007 Fourth Quarter and Full Year Financial Results
02/20/2008
Lexicon to Report Fourth Quarter and Full Year 2007 Financial Results on March 6, 2008
01/02/2008
Lexicon Pharmaceuticals to Present at the 26th Annual JPMorgan Healthcare Conference
12/20/2007
Lexicon Files Investigational New Drug Application for LX1032 as a Potential Treatment for Carcinoid Syndrome
12/09/2007
Lexicon Pharmaceuticals to Present at RBC Capital Markets Healthcare Conference
12/04/2007
Lexicon Initiates Phase 2A Trial of LX6171 Drug Candidate for Cognitive Disorders
«
Start
Prev
1
2
3
4
5
6
7
8
9
10
Next
End
»
Page 2 of 32
back to top
